[Influencing of tachycardia using the beta receptor blocking agent 1-isopropyl-amino-3-(o-allyl-oxyphenoxy)-2-propanol hydrochloride (Trasicor)].
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D013565:Sympatholytics / Q000627:therapeutic use*; D013566:Sympathomimetics / Q000008:administration & dosage; D013610:Tachycardia / Q000188:drug therapy*; D013997:Time Factors
D013565:Sympatholytics; D013566:Sympathomimetics
Tachykardiebeeinflussung durch den beta-Rexeptoren-Blocker 1-isopropyl-amino-3-(o-allyl-oxyphenoxy)-2-propanol-hydrochlorid (Trasicor)